ReviewTranslational psychiatry2026
From heterogeneity to translation: data‑driven subtyping of autism in a multilevel framework.
Review in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autism spectrum disorder (ASD) exhibits pronounced heterogeneity across genetic, neurobiological, and clinical phenotypic levels, posing substantial challenges for mechanistic elucidation and clinical translation. This review synthesizes advances in data-driven approaches to parsing ASD heterogeneity and centers the discussion on three complementary strata: neural, behavioral, and transdiagnostic subtypes. At the neuroimaging level, studies leveraging features such as functional connectivity and brain structure have consistently identified two core neurosubtypes characterized by increased and decreased neural activity, respectively. These neurosubtypes differ in time-varying dynamics, spatial architecture, and network hierarchy, and they are closely associated with specific symptom dimensions and cognitive functions. At the behavioral level, data-driven methods delineate phenotypes along axes of severity and functional impairment, and further reveal their links to neural circuits. Transdiagnostic investigations indicate that ASD and frequently co-occurring disorders share neurobiological substrates and cognitive endophenotypes. Collectively, these findings argue against a simple one-to-one correspondence between behavioral and neural subtypes; instead, the evidence is more consistent with multi-to-one, one-to-many, or many-to-many mappings that converge on the overall functional impairment. Notwithstanding this progress, major challenges remain, including sample heterogeneity, methodological inconsistency, and the integration of categorical and dimensional models. Future research should prioritize large samples, multi-site collaboration, longitudinal designs, and transdiagnostic frameworks, coupled with reverse validation via intervention response, to build robust evidence for mechanism-informed individualized assessment and intervention in ASD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.